Cargando…

The landscape of genetics and biomarkers in bladder cancer

Detalles Bibliográficos
Autor principal:	Rink, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760383/ https://www.ncbi.nlm.nih.gov/pubmed/29354489 http://dx.doi.org/10.21037/tau.2017.11.12

Ejemplares similares

Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
por: Rink, Michael, et al.
Publicado: (2016)

Changing landscape of diagnosis and treatment of bladder cancer
por: Kim, Wun-Jae
Publicado: (2016)

Biomarkers for bladder cancer: The search continues!
por: Hong, Sung Kyu
Publicado: (2016)

Bladder cancer biomarkers: Past and future directions
por: Rodriguez‐Homs, Miguel, et al.
Publicado: (2021)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Omics Landscape in Disease Biomarkers Discovery
por: Neagu, Monica, et al.
Publicado: (2016)

A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
por: Matuszczak, Milena, et al.
Publicado: (2022)

A novel bladder cancer urinary biomarker: can it go where no marker has gone before?
por: Dobbs, Ryan W., et al.
Publicado: (2018)

Gastrointestinal Cancers: Molecular Genetics and Biomarkers
por: Sharma, Kiran L., et al.
Publicado: (2018)

B2M, JAK2 and MET in the genetic landscape of immunotolerance in lung cancer
por: Sanchez-Cespedes, Montse
Publicado: (2018)

Bladder Conditions in Pediatric Patients: Genetics and Genomics
por: Piergentili, Roberto
Publicado: (2016)

New discoveries in the molecular landscape of bladder cancer
por: Li, Roger, et al.
Publicado: (2016)

Bladder Cancer
por: Kader, A. Karim
Publicado: (2011)

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics
por: Maron, Bradley A.
Publicado: (2020)

Bladder Cancer highlighted
por: Favorito, Luciano A.
Publicado: (2020)

Online tools for patient counseling in bladder and kidney cancer—ready for prime time?
por: Gild, Philipp, et al.
Publicado: (2017)

High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
por: Pichler, Renate, et al.
Publicado: (2018)

Illumination of a Vision 2020—Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions—Dream or Nightmare?
por: Ecke, Thorsten H., et al.
Publicado: (2020)

Mutational Landscape and Environmental Effects in Bladder Cancer
por: Hayashi, Takuji, et al.
Publicado: (2020)

Advanced Bladder Cancer: Changing the Treatment Landscape
por: Bilim, Vladimir, et al.
Publicado: (2022)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

Biotechnology landscape in cancer drug discovery
por: Neagu, Monica, et al.
Publicado: (2015)

Autism: From Genetics to Biomarkers
por: Voineagu, Irina
Publicado: (2012)

Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants
por: Moss, Benjamin J., et al.
Publicado: (2023)

Liquid biopsies for bladder cancer
por: Ward, Douglas G., et al.
Publicado: (2017)

Bladder cancer and the Notch pathway
por: Fernandez-Marcos, Pablo J., et al.
Publicado: (2015)

Nutritional habits and bladder cancer
por: Lippi, Giuseppe, et al.
Publicado: (2018)

Editorial: Superficial Bladder Cancer
por: Kirkali, Ziya
Publicado: (2006)

Advances in Management of Bladder Cancer
por: Racioppi, Marco
Publicado: (2021)

Female with bladder cancer: what and why is there a difference?
por: Marks, Phillip, et al.
Publicado: (2016)

Editorial: Special Issue “Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)”
por: Neuhaus, Jochen, et al.
Publicado: (2022)

Genetic polymorphisms may explain association between alcohol consumption and bladder cancer risk in East Asian men
por: Fankhauser, Christian Daniel, et al.
Publicado: (2018)

Why is the principle of “as much radicality as needed, as much organ preservation as possible” only insufficiently implemented in daily practice in the surgical treatment of penile cancer patients?
por: May, Matthias, et al.
Publicado: (2020)

Illumination of a Vision—How Arthur Rimbaud Will Give Us Motivation to Find New Input into Bladder Cancer Biomarker Research
por: Ecke, Thorsten H., et al.
Publicado: (2017)

Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients
por: Tan, Zheng, et al.
Publicado: (2018)

Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
por: Ecke, Thorsten H., et al.
Publicado: (2020)

The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
por: Riethdorf, Sabine, et al.
Publicado: (2017)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a606du0i8ooe2kaev72e2mh2jo